Xu et al. [23] found that inhibiting lysine-specific demethylase 1 reduced the expression of CD47 and PD-L1 in cervical cancer subcutaneous transplants and that blocking CD47/PD-L1 enhanced its therapeutic effect. The gene discussed is CD47; the disease is cervical cancer.